HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,914 | -9.8% | 280,499 | +1.5% | 0.00% | – |
| Q2 2023 | $320,423 | -22.4% | 276,227 | +1.0% | 0.00% | – |
| Q1 2023 | $413,040 | +21.4% | 273,536 | +101.0% | 0.00% | – |
| Q4 2022 | $340,300 | -43.4% | 136,120 | -4.3% | 0.00% | – |
| Q3 2022 | $601,000 | +53.7% | 142,255 | +1.5% | 0.00% | – |
| Q2 2022 | $391,000 | -49.3% | 140,168 | +4.0% | 0.00% | – |
| Q1 2022 | $771,000 | -33.5% | 134,799 | +6.2% | 0.00% | – |
| Q4 2021 | $1,160,000 | -83.1% | 126,978 | -80.2% | 0.00% | -100.0% |
| Q3 2021 | $6,848,000 | -30.1% | 640,610 | +1.5% | 0.00% | 0.0% |
| Q2 2021 | $9,793,000 | -41.2% | 630,983 | -38.6% | 0.00% | 0.0% |
| Q1 2021 | $16,646,000 | -27.9% | 1,026,851 | -5.9% | 0.00% | -50.0% |
| Q4 2020 | $23,087,000 | +38.4% | 1,090,816 | -3.1% | 0.00% | 0.0% |
| Q3 2020 | $16,686,000 | -40.9% | 1,125,888 | -41.3% | 0.00% | -33.3% |
| Q2 2020 | $28,210,000 | -4.6% | 1,917,768 | -23.9% | 0.00% | -25.0% |
| Q1 2020 | $29,580,000 | -80.9% | 2,519,602 | -61.7% | 0.00% | -76.5% |
| Q4 2019 | $154,687,000 | -1.6% | 6,582,410 | -22.5% | 0.02% | -10.5% |
| Q3 2019 | $157,191,000 | +4.6% | 8,496,789 | +5.1% | 0.02% | +5.6% |
| Q2 2019 | $150,247,000 | -27.5% | 8,082,178 | -4.6% | 0.02% | -28.0% |
| Q1 2019 | $207,101,000 | -0.6% | 8,473,847 | +5.5% | 0.02% | -13.8% |
| Q4 2018 | $208,423,000 | -31.3% | 8,034,803 | -16.2% | 0.03% | -14.7% |
| Q3 2018 | $303,508,000 | -30.8% | 9,589,513 | -15.1% | 0.03% | -32.0% |
| Q2 2018 | $438,654,000 | +50.0% | 11,290,956 | +6.5% | 0.05% | +42.9% |
| Q1 2018 | $292,484,000 | +67.9% | 10,597,257 | +10.1% | 0.04% | +75.0% |
| Q4 2017 | $174,158,000 | +32.9% | 9,622,009 | +18.6% | 0.02% | +25.0% |
| Q3 2017 | $131,066,000 | +17.6% | 8,115,509 | +0.8% | 0.02% | +14.3% |
| Q2 2017 | $111,482,000 | -7.5% | 8,049,235 | +0.2% | 0.01% | -6.7% |
| Q1 2017 | $120,464,000 | +56.6% | 8,030,880 | +36.7% | 0.02% | +50.0% |
| Q4 2016 | $76,934,000 | -23.7% | 5,872,839 | +0.4% | 0.01% | -23.1% |
| Q3 2016 | $100,835,000 | +1.7% | 5,852,294 | +6.5% | 0.01% | -7.1% |
| Q2 2016 | $99,156,000 | -3.8% | 5,493,420 | +1.2% | 0.01% | 0.0% |
| Q1 2016 | $103,105,000 | -28.4% | 5,429,452 | +0.7% | 0.01% | -26.3% |
| Q4 2015 | $143,921,000 | +10.3% | 5,390,298 | +0.8% | 0.02% | 0.0% |
| Q3 2015 | $130,523,000 | +137.0% | 5,349,302 | +202.7% | 0.02% | +171.4% |
| Q2 2015 | $55,065,000 | +879.5% | 1,767,161 | +287.3% | 0.01% | +600.0% |
| Q2 2014 | $5,622,000 | -17.2% | 456,320 | -6.5% | 0.00% | 0.0% |
| Q1 2014 | $6,786,000 | – | 487,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |